Mutation-specific pharmacology of the long QT syndrome.

Abstract excerpt

The congenital long QT syndrome is a rare disease in which inherited mutations of genes coding for ion channel subunits, or channel interacting proteins, delay repolarization of the human ventricle and predispose mutation carriers to the risk of serious or fatal arrhythmias. Though a rare disorder, the long QT syndrome has provided invaluable insight from studies that have bridged clinical and pre-clinical (basic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Action Potentials
• Share to Anesthetics, Local
• Share to Heart